SUMO1P3 and hepatocellular carcinoma: The absence of miR‐320a could reverse anti‐tumour action caused by the knockdown of SUMO1P3. Taken together, SUMO1P3 contributed to malignant progression of HCC through activating Wnt/β‐catenin pathway via negatively regulating miR‐320a.